Ichiro Kubota

Title: Ichiro Kubota: Innovator in Peptide Engineering

Introduction

Ichiro Kubota is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of peptide engineering, particularly in the development of novel peptide precursors. His work has implications for various physiological applications, showcasing the intersection of biotechnology and medicine.

Latest Patents

Ichiro Kubota holds a patent for a precursor of a C-terminal amidated calcitonin. This precursor is represented by the general formula P-X-Gly-Y.sub.n, where P is a peptide residue, X is an amino acid residue that can be converted in vivo to a --CONH.sub.2 group, Gly is a glycine residue, and Y is a basic amino acid residue. The integer n ranges from 2 to 4, and additional amino acid residues may be attached to Y.sub.n. This innovative precursor exhibits in vivo physiological activity similar to that of the C-terminal amidated peptide, produced through gene engineering technology.

Career Highlights

Ichiro Kubota is associated with Suntory Limited, a company known for its advancements in various sectors, including food and beverage, health, and wellness. His work at Suntory has allowed him to explore the potential of peptide applications in health-related products.

Collaborations

Ichiro has collaborated with notable colleagues such as Shoji Tanaka and Kazuhiro Ohsuye. Their combined expertise has contributed to the successful development of innovative peptide technologies.

Conclusion

Ichiro Kubota's contributions to peptide engineering highlight the importance of innovation in biotechnology. His patent for a C-terminal amidated calcitonin precursor exemplifies the potential for advancements in medical applications. His work continues to inspire future research in the field.